MedTrace Logo

Efficacy and Safety of Ciprofol in Laparoscopic Sleeve Gastrectomy

NCT05522998 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 212

Last updated 2024-08-28

No results posted yet for this study

Summary

To evaluate the efficacy and safety of ciprofol for the induction of general anesthesia in obese patients undergoing laparoscopic sleeve gastrectomy. A randomized, parallel, propofol injection positive control study will be conducted to select obese patients who will undergo laparoscopic sleeve gastrectomy in the author's hospital. To evaluate the efficacy and safety, the main observation index, secondary observation indexes, safety evaluation indexes, and the incidence of postoperative adverse reactions will be recorded and compared between the two groups.

Conditions

  • Bariatric Surgery

Interventions

DRUG

Ciprofol

Ciprofol (0.4-0.5mg/kg) for anesthesia induction

DRUG

Propofol

propofol(2-2.5mg/kg) for anesthesia induction

Sponsors & Collaborators

  • The Third People's Hospital of Chengdu

    lead OTHER

Principal Investigators

  • Xiaowei Chi, M.D. · Third People's Hospital of Chengdu, Southwest Jiaotong University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-01
Primary Completion
2023-06-30
Completion
2024-07-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05522998 on ClinicalTrials.gov